Corrigendum to “Risk adapted chemotherapy for localised Ewing’s sarcoma of bone: The French EW93 study” [Eur. J. Cancer 48 (9) (2012) 1376–1385]

Department of Paediatric and Adolescent Oncology, Institut Gustave Roussy, Villejuif, France Department of Biostatistics, Institut Gustave Roussy, Villejuif, France Department of Paediatric Oncology, Institut d’Hemato-Oncologie Pediatrique, Lyon, France Department of Paediatric Oncology, Institut Curie, Paris, France Department of Paediatric Oncology, Hopital La Timone, Marseille, France Department of Paediatric Hematology-Oncology, Hopital Trousseau, Paris, France Department of Medical Oncology, Centre Claudius Regaud, Toulouse, France Department of Paediatric Oncology, Centre Oscar Lambret, Lille, France Department of Paediatric Hematology Oncology, Hopital Clocheville, Tours, France Department of Paediatric Hematology Oncology, Centre Hospitalie Regional de Besanc on, Besanc on, France Department of Paediatric Hematology Oncology, Hopital d’enfants, Nancy, France Department of Medical Oncology, Institut Bergonnie, Bordeau, France Department of Paediatric Hematology Oncology, Centre Hospitalie Universitaire, Caen, France Department of Paediatric Hematology Oncology, Centre Hospitalie Universitaire, Rennes, France Department of Paediatric Hematology Oncology, Hopiyal americain, Reins, France Department of Paediatric Hematology Oncology, Hopital Charles Nicolle, Rouen, France Department of Paediatric Hematology Oncology, CHU A. Michalon, Grenoble, France Department of Paediatric Hematology Oncology, Hopital Hautepierre, Strasbourg, France